Topical Application of Sesame Oil for the Prevention of Chemotherapy- Induced Oral Mucositis: Pilot Study in Seven Hematopoietic Cancer Patients : Table 3

Table 3: Outline of the subjects.

HD-AC: High dose Ara-C therapy
Das: Dasatinib
HD-MA: High dose MTX-Ara-C therapy
H-CVAD: Hyper CPA+ Doxorubicin+ Vincristine+ Dexamethasone
IDA: Idarubicin
MTX: Methotrexate
PSL: Predonisolone
Anticancer agents with higher risk of oral mucositis are indicated as bold and underlined letter.

	Sesame oil group							Centering
Subject	A	B	C	D	E	F	G	H	I	J	K
Diagnosis	AML	AML	NHL	NHL (recuurence)	AML	NHL	ALL	ALL	NHL (recuurence)	AML	AML
Sex	M	M	F	F	M	M	F	F	M	M	M
Age	57	62	87	67	79	31	63	74	67	43	46
Regimen	Consolidation therapy #4	Consolidation therapy (HDAC) #2	CHOP therapy	CHOP therapy	No data	Remission induction therapy	Das/HD-MA	Das+H-CVAD therapy #4	ESHAP therapy #2	IDA-Ara-C therapy #1	Arsenic trioxide therapy
Anticancer agents	Gemtuzumab ozogamicin MTX (Intrathecal injection) Ara-C, PSL	Ara-C PSL	Rituximab CPA Vincristine PSL	CPA Doxorubicin Vincristine PSL	Enocitabine Etoposide Vindesine	Vincristine Daunorubicin CPA Asparaginase PSL	MTX Cytarabine	CPA Doxorubicin Vincristine Dexamethasone Dasatinib	Etoposide Cisplatin Methyl-PSL Ara-C	Idarubicin Ara-C	Arsenic trioxide